Shandong Weigao Blood Purification Products Co (SHSE:603014) Cash Flow for Dividends: ¥0 Mil (TTM As of Mar. 2026)


SHSE:603014 Shandong Weigao Blood Purification Products Co Ltd SHSE:603014
38 GF Score
Price ¥33.15
! 2 Warning Signs
View Full Analysis

What is Shandong Weigao Blood Purification Products Co Cash Flow for Dividends?

Shandong Weigao Blood Purification Products Co SHSE:603014 -0.15% 38 Cash Flow for Dividends is ¥0 Mil as of Mar. 2026. GuruFocus rates SHSE:603014 with a GF Score™ of 38/100. The stock has 2 warning signs investors should review.

Shandong Weigao Blood Purification Products Co's cash flow for dividends for the three months ended in Mar. 2026 was ¥0 Mil. Its cash flow for dividends for the trailing twelve months (TTM) ended in Mar. 2026 was ¥0 Mil.

Note: A negative number here means the payment of dividends. When pays more dividends, the absolute value gets bigger.

Shandong Weigao Blood Purification Products Co's annual payment of dividends declined from Dec. 2023 (¥-0 Mil) to Dec. 2024 (¥0 Mil) but then increased from Dec. 2024 (¥0 Mil) to Dec. 2025 (¥-66 Mil).

Shandong Weigao Blood Purification Products Co Cash Flow for Dividends Related Terms

Shandong Weigao Blood Purification Products Co Cash Flow for Dividends Historical Data

* Premium members only.

The historical data trend for Shandong Weigao Blood Purification Products Co's Cash Flow for Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shandong Weigao Blood Purification Products Co Cash Flow for Dividends Chart

Shandong Weigao Blood Purification Products Co Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cash Flow for Dividends
Get a 7-Day Free Trial -42.71 -18.84 -0.49 0.00 -65.83

Shandong Weigao Blood Purification Products Co Quarterly Data
Dec20 Dec21 Dec22 Jun23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cash Flow for Dividends Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
SHSE:603014
38GF Score
Shandong Weigao Blood Purification Products Co Ltd SHSE:603014
Cash Flow for Dividends is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Shandong Weigao Blood Purification Products Co Cash Flow for Dividends Calculation

Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Cash Flow for Dividends for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Cash Flow for Dividends of ¥0 Mil mean?
Shandong Weigao Blood Purification Products Co (SHSE:603014) has a Cash Flow for Dividends of ¥0 Mil as of Mar. 2026. Cash Flow for Dividends represent the amount a company pays as dividends for a specific accounting period. View historical data for Shandong Weigao Blood Purification Products Co and its competitors.
Is Shandong Weigao Blood Purification Products Co's Cash Flow for Dividends too high?
Shandong Weigao Blood Purification Products Co's current Cash Flow for Dividends is ¥0 Mil. Overall, Shandong Weigao Blood Purification Products Co has a GF Score™ of 38/100, reflecting its overall financial health beyond just this single metric.
How does Shandong Weigao Blood Purification Products Co's Cash Flow for Dividends compare to ABT and SYK?
Shandong Weigao Blood Purification Products Co's Cash Flow for Dividends of ¥0 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Flow for Dividends for a Medical Devices & Instruments company?
A good Cash Flow for Dividends depends on the Medical Devices & Instruments industry context. However, Cash Flow for Dividends should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Flow for Dividends mean?
A high Cash Flow for Dividends can signal that a stock is expensive relative to its fundamentals. Cash Flow for Dividends represent the amount a company pays as dividends for a specific accounting period. View historical data for Shandong Weigao Blood Purification Products Co and its competitors. Shandong Weigao Blood Purification Products Co's current Cash Flow for Dividends is ¥0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shandong Weigao Blood Purification Products Co stock overvalued right now?
Shandong Weigao Blood Purification Products Co (SHSE:603014) has a current Cash Flow for Dividends of ¥0 Mil. The current Cash Flow for Dividends is ¥0 Mil. Shandong Weigao Blood Purification Products Co's overall GF Score™ is 38/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Flow for Dividends calculated?
Cash Flow for Dividends is calculated from a company's financial statements. For Shandong Weigao Blood Purification Products Co (SHSE:603014), the current Cash Flow for Dividends is ¥0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Shandong Weigao Blood Purification Products Co Business Description

Address No. 7, Weigao West Road, Torch High-tech Industrial Development Zone, Shandong Province, Weihai, CHN, 264200
Shandong Weigao Blood Purification Products Co Ltd engaged in research and development, production and sales of blood purification medical products.
38GF Score

Get the complete analysis for SHSE:603014

Cash Flow for Dividends is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥33.15
Price